ChemPartner has a world-class Biologics Drug Discovery organization, with the experience and capabilities to discover, express, purify, and analyze monoclonal antibodies and recombinant proteins for our partners. Our staff of over 150 scientists is led by Western-trained PhDs with many years of pharmaceutical company experience. The biologics department has already demonstrated many capabilities for a wide variety of clients including large pharmaceutical companies, biotech companies, virtual biotech companies and academic groups.
The Antibody Discovery Group has the capabilities to develop antibody-drug conjugates, humanized mouse monoclonal antibodies and affinity matured monoclonal antibodies. We have also discovered novel high-affinity monoclonal antibodies by hybridoma technology (including human antibodies from mice) and phage display technology.
The Protein Science Group are experts in the expression of recombinant proteins in all modern expression systems and purification of client targets. Although focused on large-scale antibody production, the group is also experienced in supporting integrated services and customized protein production services.
The Protein Analytical Group has constructed production cell lines that can be used to express monoclonal antibodies in large scale to support our pharmaceutical and biotechnology partners’ IND filings and human clinical trials.